A Combination of Cardamonin and Doxorubicin Selectively Affect Cell Viability of Melanoma Cells: An In Vitro Study

Lara Ebbert(Düsseldorf University Hospital), Peter Brenneisen(Düsseldorf University Hospital)
Antioxidants
July 19, 2024
Cited by 3


Related Papers